NOTABLE LABS LTD (NTBL) Stock Price & Overview
NASDAQ:NTBL • IL0012002452
Current stock price
The current stock price of NTBL is 0.2479 USD. Today NTBL is down by -27.68%. In the past month the price decreased by -45.4%. In the past year, price decreased by -90.85%.
NTBL Key Statistics
- Market Cap
- 2.395M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -6.91
- Dividend Yield
- N/A
NTBL Stock Performance
NTBL Stock Chart
NTBL Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NTBL. When comparing the yearly performance of all stocks, NTBL is a bad performer in the overall market: 98.93% of all stocks are doing better.
NTBL Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NTBL. Both the profitability and financial health of NTBL have multiple concerns.
NTBL Earnings
On August 14, 2024 NTBL reported an EPS of -0.55 and a revenue of 2.00K. The company missed EPS expectations (-25.98% surprise).
NTBL Forecast & Estimates
8 analysts have analysed NTBL and the average price target is 9.18 USD. This implies a price increase of 3603.11% is expected in the next year compared to the current price of 0.2479.
NTBL Groups
Sector & Classification
NTBL Financial Highlights
Over the last trailing twelve months NTBL reported a non-GAAP Earnings per Share(EPS) of -6.91. The EPS increased by 65.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -152.09% | ||
| ROE | -232.9% | ||
| Debt/Equity | 0.03 |
NTBL Ownership
NTBL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 369.265B | ||
| AMGN | AMGEN INC | 15.24 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 11.03 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.53 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NTBL
Company Profile
Notable Labs Ltd. engages in the development of predictive medicines for patients with cancer. The company is headquartered in Foster City, California and currently employs 16 full-time employees. The company went IPO on 2014-09-30. The firm has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The firm's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
Company Info
IPO: 2014-09-30
NOTABLE LABS LTD
320 Hatch Drive
Foster City CALIFORNIA US
Employees: 16
Phone: 14158512410
NOTABLE LABS LTD / NTBL FAQ
What does NOTABLE LABS LTD do?
Notable Labs Ltd. engages in the development of predictive medicines for patients with cancer. The company is headquartered in Foster City, California and currently employs 16 full-time employees. The company went IPO on 2014-09-30. The firm has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The firm's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
What is the stock price of NOTABLE LABS LTD today?
The current stock price of NTBL is 0.2479 USD. The price decreased by -27.68% in the last trading session.
Does NOTABLE LABS LTD pay dividends?
NTBL does not pay a dividend.
What is the ChartMill rating of NOTABLE LABS LTD stock?
NTBL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the analyst forecast for NTBL stock?
8 analysts have analysed NTBL and the average price target is 9.18 USD. This implies a price increase of 3603.11% is expected in the next year compared to the current price of 0.2479.
What is the market capitalization of NTBL stock?
NOTABLE LABS LTD (NTBL) has a market capitalization of 2.39M USD. This makes NTBL a Nano Cap stock.
What is the ownership structure of NOTABLE LABS LTD (NTBL)?
You can find the ownership structure of NOTABLE LABS LTD (NTBL) on the Ownership tab.